New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories.

Thermo Fisher Scientific, announced an exclusive distribution agreement with Aesku.Group (Aesku), to market, sell, and support their portfolio of FDA-Cleared IFA products, automated instruments, and software in the United States.

Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease.

Innovation provides United States with first workflow update in 25 years.

PlaqueTec announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.

Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents.

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States.

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.